Singapore · Tuesday, October 6, 2026
asianomistAsia’s economy, daily.
Home / Markets / IPO & Deals

Markets.

Indian IPOs: Vishal Nirmiti, Nityas Gems Draw Varied Demand
IPO & Deals

Indian IPOs: Vishal Nirmiti, Nityas Gems Draw Varied Demand

Vishal Nirmiti’s public offering is 57% subscribed with an estimated ₹240 listing, while Nityas Gems & Jewellery reached 69% subscription, potentially listing at ₹79.

IPO & Deals

SK Group Chairman Chey to sell US$700 million SK Corp stake

Chey Tae-won will divest a 2.26 per cent interest in the South Korean conglomerate's holding firm, with the sale scheduled to begin on 2 November to fund a record divorce settlement.

IPO & Deals

Accrelist defends MClean divestment terms, buyer independence to SGX

Singapore-listed Accrelist yesterday clarified its RM30 million MClean Technologies divestment to the Singapore Exchange, addressing queries on pricing, buyer independence, and funding capability.

IPO & Deals

Anthropic targets US$2 trillion IPO, warns of AI economic shift

The artificial intelligence firm's confidential prospectus, reviewed by Reuters, asserts that AI will reshape the global economy more profoundly than past industrial revolutions.

IPO & Deals

Ligent Technologies jumps 4.6% on Hong Kong debut, raises HK$5.6bn

The optical communications unit of Hisense Group closed its first trading day last Tuesday with a valuation exceeding HK$35 billion, as mainland firms seek overseas capital.

IPO & Deals

Eswin Seeks US$300 Million Hong Kong IPO, Trading October 8

Chinese RISC-V chipmaker Beijing Eswin Computing Technology will begin soliciting investor orders on Monday for its Hong Kong initial public offering, aiming to raise around US$300 million.

IPO & Deals

NSE India IPO raises $2.4bn, valued at $46.9bn

The National Stock Exchange of India completed its initial public offering on September 24, issuing 126.4 million shares at INR1,785 each.

IPO & Deals

Dewi Negara Fachri & Partners adds two finance partners

The corporate and finance lawyers join the Jakarta-based firm's association with Hogan Lovells Cadwalader, strengthening its legal services for Indonesian deals.

IPO & Deals

RBL Bank raises $350m in international debt debut

The Mumbai-headquartered lender issued senior unsecured notes at 5.791% via a Euro medium-term note programme.

IPO & Deals

HKU, Gobi Partners Seek New Funding for HK Tech Startups

A joint delegation from the University of Hong Kong and Gobi Partners visited Astana and Tashkent, engaging with venture capital funds to identify new financing structures for Hong Kong's technology startups.

IPO & Deals

Singapore's Clifford Capital secures $802.4m in oversubscribed IABS issue

The Bayfront IX offering was two times oversubscribed, showing strong investor demand for infrastructure debt across Asia and globally.

IPO & Deals

Iambic Therapeutics, backed by Nvidia and QIA, files for US IPO

The drug developer, which has raised $461.8 million, joins a series of biotech listings capitalising on drug advancements and M&A activity this year.

IPO & Deals

NSE Listing on BSE to Trigger Indian Fund Portfolio Rebalance

India's National Stock Exchange will debut on 24 September at ₹1,785 a share, prompting mutual funds to review holdings in its rival, BSE.

IPO & Deals

Hero Motors, NSE IPOs Show Divergent Indian Unlisted Market Realities

Investors in Hero Motors face steep losses after its IPO priced 72% below unlisted trades, contrasting sharply with NSE shares that commanded a premium before listing.

IPO & Deals

Kuku Technologies Secures SEBI Approval for ₹3,500 Crore IPO

India's Kuku Technologies, a digital audio and video content platform, plans to fund technology, content production, and global expansion with proceeds from its upcoming public offering.

IPO & Deals

GSK secures global rights to Chimagen cancer drug in US$750 million deal

British pharmaceutical firm GSK announced on Tuesday its acquisition of global rights to a T-cell engager from Chengdu-based Chimagen Biosciences for treating multiple myeloma.

IPO & Deals

Prasol Chemicals IPO Opens, Grey Market Premium Points to 8% Gain

Prasol Chemicals' ₹500 crore initial public offering (IPO) began bidding today. The speciality chemicals firm aims to raise capital. Grey market premiums (GMP) point to a potential 8% listing gain. Initial subscription levels remain modest.

IPO & Deals

Brookfield completes A$4.1bn acquisition of Reliance Worldwide

The global plumbing and heating systems manufacturer, listed on the ASX, operates across Asia-Pacific, EMEA, and the Americas.